Schlafender Hase
e-Labelling Strategy for Medical Device Packaging
Pages
13
Time to read
30 mins
Publication
Language
English
Pages
13
Time to read
30 mins
Publication
Language
English
This guide details the transition towards e-labelling in the medical device industry, focusing on the implications for manufacturers and suppliers. As regulatory frameworks evolve, such as the EU's Medical Device Regulation (MDR) and its in-vitro equivalent, the need for updated electronic instructions for use (e-IFUs) is becoming critical. The document outlines the phased approach to implementing e-labelling, starting with professional users and eventually extending to patients. It discusses the benefits of moving away from traditional paper-based information, including improved accuracy, reduced environmental impact, and enhanced operational efficiencies. The guide emphasizes the importance of adapting internal processes and IT infrastructure to support this shift. Moreover, it highlights the potential challenges manufacturers may face during the transition, including necessary adjustments to systems and staff training. Overall, the document serves as a roadmap for navigating the regulatory changes and capitalizing on the advantages presented by e-labelling in medical device packaging.